| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Should Survivors of Myocardial Infarction With Low Ejection Fraction BeRoutinely Referred to Arrhythmia Specialists? |
Stevenson, W.G.;Ridker, P.M.; |
ACC Current Journal Review |
1996-11-01 |
查看 |
| Novel risk factors for systemic atherosclerosis. A comparison of C-reactiveprotein, fibrinogen, homocysteine, lipoprotein (a), and standardcholesterol screening as predictors of peripheral arterial disease |
Ridker, P.M.;Stampfer, M.J.;Rifai, N.; |
ACC Current Journal Review |
2001-09-01 |
查看 |
| Rapid reduction in C-reactive protein with cerivastatin among 785 patientswith primary hypercholesterolemia |
Ridker, P.M.;Rifai, N.;Lowenthal, S.P.; |
ACC Current Journal Review |
2001-09-01 |
查看 |
| Measurement of C-reactive protein for the targeting of statin therapy inthe primary prevention of acute coronary events |
Ridker, P.M.;Rifai, N.;Clearfield, M.;the Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators; |
ACC Current Journal Review |
2001-11-01 |
查看 |
| Effect of statin therapy on C-reactive protein levels. The pravastatininflammation/CRP evaluation (PRINCE): a randomized trial and cohort study |
Albert, M.A.;Danielson, E.;Rifai, N.;Ridker, P.M.; |
ACC Current Journal Review |
2001-11-01 |
查看 |
| Projected life-expectancy gains with statin therapy for individuals withelevated C-reactive protein levels |
Blake, G.J.;Ridker, P.M.;Kuntz, K.M.; |
ACC Current Journal Review |
2002-11-01 |
查看 |
| Plasma homocysteine concentration, statin therapy, and the risk of firstacute coronary events |
Ridker, P.M.;Shih, J.;Cook, T.J.; |
ACC Current Journal Review |
2002-11-01 |
查看 |
| Projected life-expectancy gains with statin therapy for individuals withelevated C-reactive protein levels |
Blake, G.J.;Ridker, P.M.;Kuntz, K.M.; |
ACC Current Journal Review |
2002-11-01 |
查看 |
| Plasma homocysteine concentration, statin therapy, and the risk of firstacute coronary events |
Ridker, P.M.;Shih, J.;Cook, T.J.; |
ACC Current Journal Review |
2002-11-01 |
查看 |
| Comparison of C-reactive protein and low-density lipoprotein cholesterollevels in the prediction of first cardiovascular events |
Ridker, P.M.;Rifai, N.;Rose, L.; |
ACC Current Journal Review |
2003-03-01 |
查看 |
| Comparison of C-reactive protein and low-density lipoprotein cholesterollevels in the prediction of first cardiovascular events |
Ridker, P.M.;Rifai, N.;Rose, L.; |
ACC Current Journal Review |
2003-03-01 |
查看 |
| C-reactive protein, the metabolic syndrome, and risk of incidentcardiovascular events. An 8-year follow-up of 14,719 initially healthyAmerican women |
Ridker, P.M.;Buring, J.E.;Cook, N.R.;Rifai, N.; |
ACC Current Journal Review |
2003-05-01 |
查看 |
| C-reactive protein, the metabolic syndrome, and risk of incidentcardiovascular events. An 8-year follow-up of 14,719 initially healthyAmerican women |
Ridker, P.M.;Buring, J.E.;Cook, N.R.;Rifai, N.; |
ACC Current Journal Review |
2003-05-01 |
查看 |
| Blood pressure, c-reactive protein and risk of future cardiovascular events |
Blake, G.J.;Rifai, N.;Buring, J.E.;Ridker, P.M.; |
ACC Current Journal Review |
2004-04-01 |
查看 |
| Effect of sleep loss on c-reactive protein an inflammatory marker ofcardiovascular risk |
Meier-Ewert, H.K.;Ridker, P.M.;Rifai, N.; |
ACC Current Journal Review |
2004-04-01 |
查看 |
| Pharmacogenetic study of statin therapy and cholesterol reduction |
Chasman, D.I.;Posada, D.;Subrahmanyam, L.;Cook, N.R.;Stanton, V.P.;Ridker, P.M.; |
ACC Current Journal Review |
2004-08-01 |
查看 |
| Non-HDL Cholesterol, Apolipoproteins A-I and B"1"0"0, Standard LipidMeasures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Diseasein Women |
Ridker, P.M.;Rifai, N.;Cook, N.R.;Bradwin, G.;Buring, J.E.; |
ACC Current Journal Review |
2005-10-01 |
查看 |
| Non-HDL Cholesterol, Apolipoproteins A-I and B"1"0"0, Standard LipidMeasures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Diseasein Women |
Ridker, P.M.;Rifai, N.;Cook, N.R.;Bradwin, G.;Buring, J.E.; |
ACC Current Journal Review |
2005-10-01 |
查看 |
| A Randomized Trial of Low-Dose Aspirin in the Primary Prevention ofCardiovascular Disease in Women |
Ridker, P.M.;Cook, N.R.;Lee, I.M.; |
ACC Current Journal Review |
2005-07-01 |
查看 |
| Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg inAchieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dland C-Reactive Protein <2 mg/l. An Analysis of the PROVE-IT TIMI-22 Trial |
Ridker, P.M.;Morrow, D.A.;Rose, L.M.; |
ACC Current Journal Review |
2005-09-01 |
查看 |
| Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg inAchieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dland C-Reactive Protein <2 mg/l. An Analysis of the PROVE-IT TIMI-22 Trial |
Ridker, P.M.;Morrow, D.A.;Rose, L.M.; |
ACC Current Journal Review |
2005-09-01 |
查看 |
|
|
